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Abstract 26 
The stability of the plasmid mediated virulence factors of Bacillus anthracis, a tripartite toxin 27 
located on pXO1 and an anti-phagocytic capsule encoded by genes located on pXO2, 28 
following long term storage was investigated. A collection of 159 isolates of B. anthracis 29 
were collected from the Kars region of Turkey between 2000 and 2013 and stored at -20 ⁰C in 30 
Brucella broth supplemented with 20% glycerine. 142 isolates were recovered of which one 31 
failed to express a capsule upon primary culture. A further 35 isolates yielded a mixture of 32 
mucoid and non-mucoid colonies, the majority of which had lost the pXO2 plasmid as 33 
determined by PCR analysis. Results would suggest that pXO2 is more unstable than pXO1 34 
and that this instability increases with the length of storage. It is possible that the pXO2 35 
deficient isolates of B. anthracis described here could be developed into a vaccine to treat at 36 
risk animals in the Kars region as many animal vaccines are based upon pXO2 deficiency. 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
Introduction 48 
The storage and maintenance of well-defined bacterial isolates is one of the cornerstones of 49 
microbiology providing reproducibility and confidence in results. Long term storage can be 50 
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achieved through several different methods (agar slants, lyophilisation etc.) and has be shown 51 
to have an impact on properties of the resurrected cultures (Michel & Garcia, 2003). The 52 
maintainance of virulence characteristics is of particular importance for those working in 53 
infectious disease modelling or vaccine development. The influence of in vitro culture 54 
conditions and storage conditions on virulence has been demonstrated in bacterial species 55 
such as Flavobacterium columnare (Zhang et al.,2014) and human pathogens such as 56 
Eshcerichia coli and Salmonella (Huang et al., 2014; Yang et al., 2014). 57 
Bacillus anthracis is a well characterised spore forming bacterium that can establish 58 
infections in both animals and humans and was one of the first bacterial species to have an 59 
effective attenuated vaccine (Pasteur, 1881; Baillie, 2009). The virulence of B. anthracis is 60 
mediated by the production of a tripartite toxin and the presence of an antiphagocytic capsule 61 
(Green et al., 1985). The genes responsible for these factors are encoded on two seperate 62 
plasmids, pXO1 which encodes the toxins and pXO2 which carries the genes for capsule 63 
production (Hugh-Jones & Blackburn, 2009). 64 
These plasmids play a key role during infection, however, their contribution to survival 65 
outside of an infected host is less clear. Isolates lacking pXO2 have been reported in both 66 
environmental samples, as has the spontaneous loss of the plasmid during culture suggesting 67 
that under certain conditions pXO2 may be lost (Turnbull et al., 1992). The loss of pXO1 68 
appears to be more infrequent than the loss of pXO2 (Turnbull et al., 1992; Bowen & Quinn, 69 
1999; Pavan & Cairo, 2007) and may account for the routine use of the Sterne strain of B. 70 
anthracis as a live animal vaccine (Turnbull, 1991). 71 
This current investigation screened the historic B. anthracis culture collection maintained 72 
at Kafkas University since 2000 to determine the stability of pXO1 and pXO2 in Turkish 73 
isolates. In addition to determing the efficacy of the in house storage conditions on strain 74 
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survival and plasmid stability we also sought to determine if any of the isolates yielded 75 
attenuated variants that could potentially be developed into animal vaccines. 76 
 77 
Materials and Methods 78 
All culture work and identification of B. anthracis was performed in a Class II biosafety 79 
cabinet in the Veterinary Faculty of Kafkas University (Kars, Turkey). All consumables and 80 
reagents were obtained from either Fisher Scientific (Loughborough, UK) or Sigma Aldrich 81 
(Dorset, UK) unless otherwise stated in the text. 82 
 83 
Bacterial strains and revival 84 
One hundred and fifty nine B. anthracis isolates from the historical collection at Kafkas 85 
University were examined at part of this study. Isolates were obtained between 2000 and 2013 86 
from animal and environmental sources using the same cultivation methods by trained 87 
personnel. Prior to storage isolates were confirmed as B. anthracis by phenotypic assessment 88 
(i.e. colony morphology, sensitivity to penicillin G and gamma phage). Isolates were stored at 89 
-20oC in Brucella broth (Oxoid, Basingstoke, UK) supplemented with 20% glycerine. 90 
Isolates were revived by the addition of 200 µL defrosted stock to 5 mL Brain Heart 91 
infusion broth (BHI; Oxoid, Basingstoke, UK) and then incubated for 48 h at 37oC. After 92 
incubation a 0.1 mL sample was spread over the surface of a pre-prepared 7% (v/v) sheep 93 
blood agar plate and incubated at 37oC for 18-48 h. 94 
 95 
Phenotypic assessment 96 
Individual colonies were assessed using standard microbiological criteria i.e. classical B. 97 
anthracis colony morphology (ground-glass appearance, flat, opaque, tenacious and grayish-98 
white), sensitivity to penicillin G (10 Units; Oxoid, Basingstoke, UK) and gamma phage 99 
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(~109 PFU/mL). Once confirmed as B. anthracis, isolates were phenotypically assessed for 100 
the presence of the pXO1 (toxin production) and pXO2 (capsule expression) virulence 101 
plasmids. 102 
The presence of pXO1 was determined using the XO media as described by Hoffmaster & 103 
Koehler (1997). In brief, this media contained glucose (0.5% w/v), ferric chloride (40 µg/mL), 104 
thiamine hydrochloride (10 µg/mL), glycine (200 µg/mL), L-methionine (40 µg/mL), L-105 
proline (40 µg/mL), L-serine (40 µg/mL), L-threonine (40 µg/mL), (NH4)2SO4 (2 mg/mL), 106 
KH2PO4 (6 mg/mL), K2HPO4 (14 mg/mL), sodium citrate (1 mg/mL), MgSO4.7H2O (0.005 107 
mg/mL), MnSO4.H2O (0.00025 mg/mL), L-glutamic acid (2 mg/mL), and agar (1.5% w/v). 108 
Plates were then incubated for 72 h at 37oC and assessed for the presence or absence of 109 
growth (Fig. 1a). 110 
The presence of pXO2 was determined on the basis of capsule production. In brief, 111 
colonies were streaked to Nutrient Agar plates supplemented with 0.7% (w/v) Sodium 112 
bicarbonate and 10% (v/v) Horse serum (Oxoid, Basingstoke, UK; Knisely, 1965). Plates 113 
were then incubated for 48 h in candle jars at 37oC. At 24 and 48h post incubation, growth on 114 
agar plates was assessed for the production of mucoid (capsule producing) and non-muciod 115 
(non-capsule producing) colony types (Fig. 1b). In order to confirm the results obtained using 116 
candle jars, capsule production was also assessed by incubation with gradually increasing CO2 117 
concentration (between 5 and 20%) in a static incubator. 118 
Capsule production was visually confirmed using the McFadyean stain (Owen et al., 119 
2013). In brief, individual colonies were suspended in 10 µL horse serum and smeared over 120 
the surface of a microscope slide and allowed to air dry at room temperature. Slides were 121 
immersed in absolute ethanol for 10 min and allowed to air dry. A single drop of methylene 122 
blue was spread over the slide, left for 1 min and then gently rinsed with clean water and 123 
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examined under x1000 magnification using a CX21FS1 light microscope (Olympus 124 
Corporation, USA) for the presence of capsule (Fig. 1c and d). 125 
 126 
PCR assessment of pXO1 and pXO2 127 
Individual colonies of interest (non-mucoid and mucoid phenotypes) taken from bicarbonate 128 
agar plateswere used to innoculate 1.5 mL of BHI broth and incubated overnight at 37oC. 129 
Control organisms of B. anthracis Sterne (pXO1+, pXO2-), B. anthracis K-125 (pXO1+, 130 
pXO2+) and Escherichia coli OP50 were also assessed. Following incubation, overnight 131 
cultures were centrifuged at 14,000 x g for 10 min, the supernatant discarded and the pellet 132 
resuspended in 1.5 mL molecular biology grade water (Eppendorf, Germany). Centrifugation 133 
was repeated as before and the pellet resuspended in 100 µL DNase-Rnase free water 134 
(Invitrogen, UK). Samples were boiled at 100oC for 10 min in a waterbath, cooled on ice and 135 
centrifuged at 14, 000 x g for 10 s and stored at -20oC until use. 136 
A summary of primers used in the current investigation can be found in Table 1. A 50 µL 137 
reaction mixture (25µL Taq PCR Master Mix Kit (Qiagen, UK), 5µL primer, 5µL Template 138 
DNA and 15µL dH2O (supplied as part of the Taq PCR Master Mix Kit)) of each primer was 139 
then run using the following PCR conditions; 140 
For PA5/8, CAP6/103, CapBF/R, CapCF/R and pXO2-007F/R, initial denaturation step at 141 
94°C for 5 min, followed by 30 cycles of 94°C for 40 s, 58°C for 40s and 72°C for 40s with a 142 
final elongation step of 72°C for 5 min. 143 
For CapAF/R, initial denaturation step at 94°C for 5 min, followed by 30 cycles of 94°C 144 
for 40s, 45°C for 40s and 72°C for 40s with a final elongation step of 72°C for 5 min. 145 
Products were analysed on a 1% (w/v) agarose gel stained with SafeView nucleic acid 146 
stain (NBS Biologicals, Huntingdon, UK). 147 
 148 
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Statistical analysis 149 
The degree of association between plasmid profiles and storage time was measured using a 150 
chi-square statistic (Preacher, 2001). 151 
 152 
Results 153 
A total of 151 (94.9%) isolates were successfully recovered from storage for which 142 154 
(89.3%) were confirmed as B. anthracis on the basis of morphology, susceptibility to Gamma 155 
phage, penicillin sensitivity and capsule expression. 156 
Confirmed B. anthracis isolates originated from animal (n=130) and envionmental samples 157 
(n=12). The remaining 17 isolates (10.7%) were shown to be non-viable (n=8) or non B. 158 
anthracis (n=9). 159 
All isolates identified as B. anthracis also grew on XO media suggesting that they 160 
contained the pXO1 plasmid (Fig. 1a; Table 2). 161 
When cultured on bicarbonate agar in the presence of CO2,  only one isolate was non-162 
mucoid upon primary culture while a further 35 isolates yield a mixed phenotype of mucoid/ 163 
non- mucoid colonies when incubated using a candle jar. Reincubation of these non-mucoid 164 
colonies in fixed 5% CO2 atmosphere failed to restore capsule expression, while 5 of 35 165 
mixed phenotypes regained the ability to express a capsule. Non-muocid colonies from the 166 
remaining 30 isolates failed to regain capsule expression suggesting either the complete loss 167 
of pXO2 or the inactivation of genes esssential for capsule expression. 168 
PCR analysis was performed on the non-mucoid colonies obtained from all 36 isolates 169 
using primers specific for one target on pXO1 (the pag gene) and 5 targets within the pXO2 170 
plasmid, 3 of which are within the capsule synthesis operon. A total of 5 distinct PCR profiles 171 
were observed (Fig. 2; Table 3). 172 
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Profile A (n=20) comprised of pXO1 primer positive, pXO2 primers negative isolates. 173 
Repeated culture (n=3) of these non-muciod isolates in a CO2 incubator failed to restore 174 
capsule expression suggesting that the pXO2 plasmid may have been lost from these isolates. 175 
Profile B (n=10) comprised of pXO1 primer positive isolates which gave a positive 176 
response with the Cap6/103 primers but failed to produce a product with the remaining pXO2 177 
specific primers. Following repeated culture (three passages) only one isolate regained the 178 
ability to express a capsule. 179 
Pattern C (n=3) comprised isolates which yielded PCR products of the expected size from 180 
all primers. All isolates regained the ability to expression a capsule upon repeated culture in 181 
the presence of CO2. 182 
Pattern D (n=1) gave the expected size PCR products with the pXO1 specific and 183 
Cap6/103, CapB and Cap C PCR primers but did not regain the ability to express a capsule 184 
upon repeated culture (three passages). 185 
The final profile, E (n=1) failed to produce a PCR product with the pXO1 specific primers 186 
but produced expected PCR products will all pXO2 specific primers. 187 
The majority (80%) of the strains which produced a mixed capsule morphology were 188 
isolated from cattle while the remaining animal isolates came from sheep (20%). The majority 189 
(76.6%) of conversions from mucoid to non-mucoid were from strains isolated between 2000 190 
and 2003 while the remainder were from 2005 (3.3%), 2007 (3.3%), 2008 (3.3%), 2011 191 
(3.3%) and 2013 (10%) (Table 2). No significant difference (P > 0.05) was observed between 192 
the production of a non-mucoid phenotype and sample type. However, conversion to a non-193 
mucoid phenotype was found to increase significantly with increasing length of storage (P < 194 
0.05). 195 
 196 
Discussion 197 
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Although it is well established that B. anthracis spores can survive and persist in the 198 
environement for decades and still maintain the ability to establish an active infection once a 199 
suitable host arises (Wilson & Russell, 1964; De Vos, 1990), there are limited studies which 200 
investigate the effect of long term storage on viability and virulence. In this current 201 
investigation, 142 (89.3%) isolates of B. anthracis were recovered from long term storage. 202 
This recovery rate compares favourably to that of Marston and colleagues who were only able 203 
to recover 53.8% of isolates following long term storage (Marston et al.,2005). The 204 
preservation method employed in this study, a liquid medium supplemented with glycerin and 205 
the storage at -20°C may account for the greater recovery rate. 206 
The ability of B. anthracis to cause anthrax is primarily attributed to the presence of two 207 
virulence plasmids; pXO1 which carries the genes which encode the tripartite anthrax toxin 208 
(pagA, lef, and cya) and pXO2 which carries the capBCADE gene cluster which is responsible 209 
for the expression of the poly-D-glutamic acid capsule (Makino et al., 1989; Okinaka et al., 210 
1999ab; Pannucci et al., 2002; Candela & Fouet, 2005). While either plasmid can be lost from 211 
the bacteria, it is suggested that pXO2 is more susceptible to loss than pXO1 (Turnbull et al., 212 
1992; Marston et al., 2005). 213 
While the mechanisms responsible for the loss of these plasmids are unclear, factors such 214 
as genetic damage, sporulation inadequacies as a result of poor nutrient availability, 215 
temperature induced stress and the presence of antibiotics such as novobiocin have all be 216 
linked to the phenomenon in the laboratory (Ezzell, 1988; Marston et al., 2005). 217 
A single isolate (PCR profile E) failed to generate a PCR product of the expected size with 218 
our pXO1 specific primers it was able to grew on XO media suggesting the presence of at 219 
least some or all of the plasmid while all other isolates produced positive results for both PCR 220 
and culture assessment. Further studies are required to determine if this failure in PCR 221 
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assessment was due to the lost of the target DNA or a mutation in the primer recognition 222 
sequence. 223 
A single isolate was non-mucoid upon primary isolation and failed to regain capsule 224 
expression following repeated culture in a CO2 incubator. PCR screening with pXO2 specific 225 
primers failed to generate any products (profile A) suggesting a complete loss of the plasmid. 226 
A further 35 isolates yielded a mixed phenotype of mucoid/non-mucoid colonies upon 227 
primary culture. Of these non-mucoid colonies 20 failed to regain capsule expression 228 
following repeated culture on bicarbonate agar in a CO2 rich atmosphere and yielded negative 229 
results with all pXO2 specific primers (profile A) suggesting that the plasmid had been lost. 230 
This study has yielded 21 isolates from the historic collection with the potential to be 231 
developed as a live spore animal vaccine due to the non-function or absence of pX02. 232 
The next biggest group (profile B) consisted of 10 isolates of which 9 failed to regain the 233 
ability to expression a capsule upon repeated culture in a CO2 incubator. The fact that one 234 
non-mucoid colony producing isolate regained the ability to express a capsule suggests that 235 
the conditions within the candle jar may have been non-optimal. It is known that capsule 236 
expression is regulated in part by the level of CO2 in the environment where it is thought to 237 
serve as a signal of the mammalian host environment and act as cue for the induction of the 238 
virulence factors (Uchida et al., 1993; Drysdale et al., 2005). The constant level of CO2 239 
achieved by the incubator compared to the candle jar may explain the reactivation of capsule 240 
expression in this and other isolates (Fouet, 1996; Green et al., 1985). 241 
PCR analysis of all 10 isolates with pXO2 specific primers, a positive response was 242 
obtained with the Cap6/103 primers but failed to yield products with any of the remaining 243 
primers. Further studies are required to determine the reasons for this discrepancy and raises 244 
the possbility that Cap6/103 may not be specific for pXO2 as first thought. 245 
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Isolates that belonged to profile C (n=3) produced mixed mucoid/ non- mucoid colonies 246 
upon primary culture in a candle jar but regained capsule expression when cultured in a CO2 247 
incubator. PCR analysis generated products of the expected size for all of the pXO2 primers 248 
suggesting that failure to express a capsule may be due to inefficient regulation of gene 249 
expression. 250 
Profile D comprised one non-mucoid isolate which failed to regain the ability to express a 251 
capsule when cultured in a CO2 incubator. PCR primers (Cap6/103, CapB, CapC) specific for 252 
some but not all of the pXO2 located targets gave the expected gene products suggesting that 253 
the plasmid was present but had been subjected to major mutational events. 254 
The vast majority of isolates which yielded a mixed colony phenotype were intitally 255 
isolated betwween 2000 and 2003 suggesting that the length of storage has a significant 256 
impact on the stability of pXO2. The results from this study suggest that the storage of B. 257 
anthracis at -20oC in Brucella broth supplemented with 20% glycerine may not be the 258 
optimum approach with which to ensure the maintainence of the orginal properties of the 259 
isolate. 260 
 261 
Conclusions 262 
The results from this study suggests that the pXO2 plasmid is more susceptible to loss or 263 
modification when stored in Brucella broth supplemented with 20% glycerine at –20°C than 264 
pXO1 and that this instability increased with the storage duration. While the reasons for this 265 
instability have yet to be determined, a number of isolates suggest a complete loss of the 266 
pXO2 plasmid. The failure of a small number of isolates to express a capsule was linked to 267 
the use of a candle jar suggesting that this is an unreliable method with which to identify 268 
capsule producing bacteria. The reasons for the differences in pXO2 primer specificity is 269 
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currently unclear. Twenty one pXO2 deficient isolates which have the potential to be 270 
developed as animal vaccines have been recovered and characterised. 271 
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 334 
Table 1. PCR primers used for the confirmation of B. anthracis virulence plasmids 335 
Primer Sequence Plasmid Target Location 
Product 
Size (bp) Reference 
PA 8 GAGGTAGAAGGATATACGGT 2452-2471 
PA 5 TCCTAACACTAACGAAGTCG pXO1 3048-3029 596 
Beyer et al. 
(1995) 
CAP 6 TACTGACGAGGAGCAACCGA 506-525 
CAP 103 GGCTCAGTGTAACTCCTAAT pXO2 1541-1522 1035 
Beyer et al. 
(1995) 
CAPA-F CGATGACGATGGGTGAC 54942-54931 
CAPA-R AGATTGAAGTACATGCGGATG pXO2 54266-54287 676 
Wang et al. 
(2011) 
CAPB-F GACGAGGAGCAACCGATTAAG 56564-56544 
CAPB-R AAGAACGCAGGCTTAGATTGG pXO2 56014-56034 550 
Wang et al. 
(2011) 
CAPC-F GTATTAGGAGTTACACTGAGCC 55554-55533 
CAPC-R GGTAACCCTTGTCTTTGAATTG pXO2 55208-55229 345 
Wang et al. 
(2011) 
pXO2-007F GCGATGGTGGAACAGGAATG 4497-4478 
pXO2-007R TGCGTTGCTGCCGATATTG pXO2 3809-3727 688 
Wang et al. 
(2011) 
 336 
Table 2. Summary of phenotypic screening of confirmed B. anthracis isolates 337 
Phenotypic characterisation 
pXO2  
(CO2 incubator / Candle jar) 
Isolate Type N Penicillin γ Phage pXO1 
Mucoid Mixed Non-mucoid 
Cattle 114 114 114 114 89 / 85 24 / 28 1 / 1 
Sheep 15 15 15 15 9 / 9 6 / 6 - 
Dog 1 1 1 1 1 / - - / 1 - 
Soil 10 10 10 10 10 / 10 - - 
Other 2 2 2 2 2 / 2 - - 
 338 
Table 3. Virulence plasmid profiles of B. anthracis strains 339 
PCR results 
Sample Type Strainsa 
Growth 
on XO 
medium 
Capsule status PA Cap6/103 CapA CapB CapC pXO2-007 
 K125 (pXO1+, pXO2+) + Mucoid + + + + + + 
Control Sterne (pXO1+, pXO2—) + Non-mucoid + - - - - - 
 E.coli OP50 (Neg.cont.) - Non-mucoid - - - - - - 
Mixed culture- Mucoid                     30  (35) + Mucoid + + + + + + 
Pattern A   20  (20) + Non-mucoid + - - - - - 
Pattern B     9  (10) + Non-mucoid + + - - - - 
Pattern C     -    (3) + Non-mucoid + + + + + + 
Pattern D     1   (1) + Non-mucoid + + - + + - 
Mixed culture- Non-
mucoid 
Pattern E      -   (1) + Non-Mucoid - + + + + + 
Pure culture- Non-mucoid Pattern A     1   (1) + Non-Mucoid + - - - - - 
aPattern data in brackets represents samples cultured in candle jars. 340 
341 
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 342 
 343 
Fig. 1. Phenotypic screening of confirmed B. anthracis cultures. (a) B. anthracis isolate on 344 
XO media after 72 h growth. (b) B. anthracis isolates on sodium bicarbonate agar after 48 h 345 
growth (left side is mucoid and right is non-mucoid colony morphology). (c) no capsule 346 
production and (d) capsule production with McFadyean staining. . 347 
 348 
